| Authors: |
Pellegrini S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy., Potjer TP; Department of Clinical Genetics, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands., Del Bianco P; Clinical Trials and Biostatistics Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy., Vecchiato A; Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy., Fabozzi A; Oncology 3 Unit, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy., Piccin L; Oncology 2 Unit, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy., Tonello D; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy., van der Stoep N; Department of Clinical Genetics, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands., Tinsley E; Leeds Institute for Data Analytics, University of Leeds, Leeds LS2 9NL, UK., Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892-8322, USA., Iles MM; Leeds Institute for Data Analytics, University of Leeds, Leeds LS2 9NL, UK.; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK., Menin C; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy. |
